Antiviral Therapy in Cytomegalovirus-Associated Biliary Atresia
Indian J Pediatr
.
2022 Jul;89(7):732.
doi: 10.1007/s12098-022-04093-4.
Epub 2022 Mar 8.
Authors
Praveen Mathur
1
,
Priyanka Udawat
2
3
,
Priyanshu Mathur
4
,
Dilip Ramrakhiani
5
,
Sandeep K Mathur
6
,
S Sitaraman
4
,
R K Gupta
4
,
Saurav Sultania
1
,
Reshu Gupta
7
Affiliations
1
Department of Pediatric Surgery, SMS Medical College & Attached Hospitals, Jaipur, Rajasthan, India.
2
Institute of Digestive & Liver Care, S. L. Raheja Hospital, Mumbai, Maharashtra, India.
3
Department of Pediatric Medicine, SMS Medical College & Attached Hospitals, Jaipur, Rajasthan, 302004, India.
4
Department of Pediatric Medicine, SMS Medical College, Jaipur, Rajasthan, India.
5
Department of GI & Liver Pathology, SMS Medical College & Attached Hospitals, Jaipur, Rajasthan, India.
6
Department of Endocrinology & Molecular Genetic Research Lab, SMS Medical College, Jaipur, Rajasthan, India.
7
Department of Pediatric Medicine, SMS Medical College & Attached Hospitals, Jaipur, Rajasthan, 302004, India. scienceadv13@gmail.com.
PMID:
35258790
DOI:
10.1007/s12098-022-04093-4
No abstract available
Publication types
Letter
MeSH terms
Antiviral Agents / therapeutic use
Biliary Atresia* / drug therapy
Cytomegalovirus
Cytomegalovirus Infections* / complications
Cytomegalovirus Infections* / drug therapy
Humans
Infant
Liver
Substances
Antiviral Agents